经导管介入治疗在急性肺栓塞中的临床应用研究

The clinical application of interventional therapy in acute pulmonary embolism

目的探讨经导管介入治疗在急性肺血栓栓塞症的临床应用效果。方法回顾性总结15例急性肺栓塞患者的介入诊疗要点、相关治疗和中远期效果。结果全组经介入诊疗无并发症、无致残、无死亡。肺动脉收缩压由治疗前的（58±21）mm Hg降至治疗后的（36±11）mm Hg,动脉血氧分压由（57±13）mm Hg升至（91±8）mm Hg。核素肺血流灌注显像肺灌注缺损恢复,肺动脉造影充盈缺损或截断征象消失。术后随访13个月～46个月,平均29.5个月,除1例患者复发外,余均未见复发。结论肺栓塞的介入治疗是一种微创、安全、有效的治疗方法,值得推广。

Objective Clinical study of interventional treatment of pulmonary thromboembolism （PE）.Methods Retrospective summary of intervention points, 15 cases of acute pulmonary embolism in treatment and long term effect. Results The whole group after intervention and no complications, no death, no disability.Pulmonary artery systolic pressure before the treatment （58 ±21 ）mm Hg dropped after treatment （36 ± 11 ）mm Hg,arterial partial pressure of oxygen from （57 ± 13）mm Hg to （91±8）mm Hg.Radionuclide lung perfusion imaging of lung perfusion defect restoration.Vanishing lung arteriography filling defect or amputation sign.Patients were followed up for 13-.46 months, average 29.5months, But one exception, recurrence was not found.Conclusion The interventional therapy of pulmonary embolism is a safe, effective, minimally invasive treatment method.